Simple research view

DVA · DaVita Inc.

$236.31 latest stored close

Detected setup Trend Only

Watch · Quality 100/100

Ask about DVA

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$DVA

DaVita Inc.

DaVita Inc. is a large-cap Medical/Nursing Services company in the Health Services sector with a market cap of $15B.

Strong Buy · 98 Health Services Medical/Nursing Services stock Stage 2 · Advancing Base 1 Data 56m ago

$236.31 latest close

← Back Join to Watchlist $DVA Share card

Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart

Earnings-risk mode

Pre-earnings setup

Wednesday, August 5, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

DVA+0.37%

Broad market · SPY+0.02%

Same completed session window ending 2026-07-27. +0.35 points vs SPY.

CatalystUnavailable Stock reactionPositive Sector reactionUnavailable Opening surgeUnavailable Event riskEarnings-driven

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.

Price $236.31 Jul 27 close

52W High $239.64 -1.4%

52W Low $101.00

Wks Since High 2w

Base Depth -6.4%

Base B1

SMA 50 $213.41

SMA 200 $154.36

Avg Vol 791,994

RS Rank 98

RS vs High +0.0%

RS Slope +7.8% ▲

Grp Rank #15/64

ADR% 2.7%

ATR(14) $6.06 (2.6%)

Rel Vol (today) 0.79×

Vol Pace N/A

U/D Vol 1.69

A/D Days 21A / 11D

A/D Rating A+

VDU Bars 0/10 d

Power Trend 30d

Earnings 8d

$101.00

$239.64 98%

DVA Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for DVA.

Create Free Account

Setup Quality B+ 5/7 signals

Score trend

✓ Stage 2 · Advancing ✓ Power Trend 30d ✓ RS New High ✓ Trend 8/8 ✗ No Pattern ✓ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$DVA · $236.31 · as of 2026-07-27 · multi-factor read

/ 100

Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend

Weekly ▲ Uptrend

Monthly ▲ Uptrend

Moving Averages

50-day$213.41 ↑

100-day$185.14 ↑

200-day$154.36 ↑

Bullish (50 > 200)

RSI (14)

Reading65.2 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening

Histogram-1.148

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width71% · 7.9%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol1.69 · Accumulation

Rel volume0.79×

Accumulation — volume is concentrated on up days; buyers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $239.6452-week high

Price · $236.31now

S · $191.57swing level

S · $186.61swing level

S · $148.00swing level

Fibonacci · Uptrend swing

23.6%$212.58

38.2%$195.85

50.0%$182.32

61.8%$168.79

78.6%$149.53

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for DVA — plus the full 495-symbol scanner and Ask-the-Legends chat.

🔒 Start your 7-day free trial →

Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishVolume accumulation

Want this read in a legend's voice? 💬 Ask a Legend about DVA

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Watch

Minervini B

Trend-template read: 8/10 pass; wait for the soft misses to improve.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $236.31, MA150 $165.18, MA200 $154.36

1.2 150-day MA > 200-day MAMA150 $165.18 vs MA200 $154.36

Failing evidence

2. Quarterly EPS growth ≥ 25%-15.6% QoQ

2. Revenue growth ≥ 20% YoY+6.5% YoY

8/10 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 96

A: Annual earnings & revenue qualityRev +6.5% | ROE 181.2%

Failing evidence

C: Quarterly EPS acceleration ≥ 25%-15.6% QoQ

S: Volume ≥ 40% above average on breakoutVolume ratio 0.79x

4/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $236.31 vs MA200 $154.36

Failing evidence

Volume expansion above averageVolume ratio 0.79x

6/7 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$236.31

Relative strengthRS 96

Failing evidence

Volume vs average0.79x

Pivotal point cleared on expanding volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$236.31

Relative strengthRS 96

Failing evidence

Volume vs average0.79x

Box top broken on heavy volumeNot confirmed

4/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence

Price$236.31

Relative strengthRS 96

Failing evidence

Volume vs average0.79x

Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending

4/6 checks

Method → Playbook → Ask →

Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Follow-Through Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH NH

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +14 A+

Minervini · Grade Card

Fundamentals & leadership quality — Minervini SEPA criteria · 5/7 met

B 5/7 SEPA

Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ -16%

✗ Revenue growth ≥20% YoY +6%

✓ Gross margin ≥30% 32%

✓ ROE ≥17% 181%

✓ RS rating ≥80 (leadership) 96

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -1.4%

Method Playbook

📋 Trade it like O'Neil EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.

Pivot

Pro level

Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Trend Only

99.9 score

RS Score 96

Trend 8/8 ✓

Why This Setup?

Trend Only

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

2/7 universals met

In a confirmed uptrend Stage 2 · Trend 8/8
Risk is defined No stop — undefined risk
Asymmetric reward No target set
Not chasing (in range) Pivot distance unknown
Volume confirms 0.8× average — light
Clear of earnings in 8 days — size down
A relative-strength leader RS 98

Why these seven? → The Universal Edge

Minervini Trend Template

8/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $236.31 vs SMA150 $165.18 / SMA200 $154.36

SMA 150 above SMA 200 SMA150 $165.18 vs SMA200 $154.36

SMA 200 trending up Slope +10.11 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $213.41

Price above SMA 50 $236.31 vs SMA50 $213.41

30%+ above 52W low +134.0% from $101.00

Within 25% of 52W high -1.4% from $239.64

RS score above 70 RS 96

Fundamentals

52W Range

98%

Mkt Cap SEC

15.2B

EPS QoQ

-16%

Rev YoY

+6%

ROE

181%

Gross Margin

32%

D/E

77.99

EPS TTM

$9.84

P/E TTM

24.0x

Float

64M

Insider

No Buy

Company

Legend AI snapshot

DaVita Inc.

DVA · NYSE · Health Services · Medical/Nursing Services

$236.31latest close $15.2Bmarket cap 98RS rank 100setup score

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

8/8

W. RS

100

W. Support

$104.06

W. Resist

$239.64

Weekly Structure

Trend Neutral

Tight Weeks 0

Confirmation Neutral

Scan History

20× streak

Jul 28

Trend Only ✓ Gate

100

Jul 28

Trend Only ✓ Gate

100

Jul 27

Trend Only ✓ Gate

99 0.0%

Jul 27

Trend Only ✓ Gate

97 0.0%

Jul 24

Trend Only ✓ Gate

98 +0.4%

Get the full picture on DVA

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial